Once trained, machine learning algorithms can predict the properties of new antibody candidates, greatly speeding up the drug discovery process.
Generative AI models are a type of artificial intelligence that generate new data that resemble training data by understanding the underlying...
Phage display is a powerful technique for the study of protein-protein interactions and the discovery of therapeutic antibodies.
The key to the production of monoclonal antibodies (mAbs) lies in a specialized cell type known as a hybridoma.
By enabling high-throughput sequencing of entire B cell repertoires, NGS offers unprecedented insights into the diversity and dynamics of antibody...
Brentuximab Vedotin works by targeting and binding to a protein known as CD30 on cancer cells.
Trastuzumab emtansine (T-DM1) is a combination of the chemotherapy drug called emtansine and the monoclonal antibody trastuzumab.
CD30 is expressed in some tumor cells, making it a potential target for cancer immunotherapy.
Antibody-drug conjugates (ADCs) are therapeutic agents that consist of monoclonal antibodies that are linked to a small-molecule drug or a cytotoxic...
TNF inhibitors work by blocking the action of tumor necrosis factor, thereby reducing inflammation and relieving symptoms.